Literature DB >> 28680833

Endoscopic Diagnosis and Treatment of Precancerous Colorectal Lesions in Patients with Inflammatory Bowel Disease: How Does the Latest SCENIC International Consensus Intersect with Our Clinical Practice?

Dong Wu1, Jing-Nan Li1, Jia-Ming Qian1.   

Abstract

Entities:  

Year:  2017        PMID： 28680833      PMCID： PMC5490956          DOI： 10.1515/jtim-2017-0008

Source DB:  PubMed          Journal:  J Transl Int Med        ISSN： 2224-4018


× No keyword cloud information.
  12 in total

1.  Pitfalls of pit pattern diagnosis in ulcerative colitis-associated dysplasia.

Authors:  Keisuke Hata; Toshiaki Watanabe; Toru Motoi; Hirokazu Nagawa
Journal:  Gastroenterology       Date:  2004-01       Impact factor: 22.682

2.  Narrow band imaging for detection of dysplasia in colitis: a randomized controlled trial.

Authors:  Ana Ignjatovic; James E East; Venkat Subramanian; Noriko Suzuki; Thomas Guenther; Nicky Palmer; Paul Bassett; Krish Ragunath; Brian P Saunders
Journal:  Am J Gastroenterol       Date:  2012-06       Impact factor: 10.864

3.  AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease.

Authors:  Francis A Farraye; Robert D Odze; Jayne Eaden; Steven H Itzkowitz; Robert P McCabe; Themistocles Dassopoulos; James D Lewis; Thomas A Ullman; Tom James; Robin McLeod; Lawrence J Burgart; John Allen; Joel V Brill
Journal:  Gastroenterology       Date:  2010-02       Impact factor: 22.682

4.  SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease.

Authors:  Loren Laine; Tonya Kaltenbach; Alan Barkun; Kenneth R McQuaid; Venkataraman Subramanian; Roy Soetikno
Journal:  Gastroenterology       Date:  2015-03       Impact factor: 22.682

5.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis.

Authors:  J A Eaden; K R Abrams; J F Mayberry
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

6.  Narrow-band imaging as an alternative to chromoendoscopy for the detection of dysplasia in long-standing inflammatory bowel disease: a prospective, randomized, crossover study.

Authors:  Maria Pellisé; Maria López-Cerón; Cristina Rodríguez de Miguel; Mireya Jimeno; Michel Zabalza; Elena Ricart; Montserrat Aceituno; Glòria Fernández-Esparrach; Angels Ginès; Oriol Sendino; Miriam Cuatrecasas; Josep Llach; Julián Panés
Journal:  Gastrointest Endosc       Date:  2011-07-29       Impact factor: 9.427

7.  Comparison of high definition with standard white light endoscopy for detection of dysplastic lesions during surveillance colonoscopy in patients with colonic inflammatory bowel disease.

Authors:  Venkataraman Subramanian; Vidyasagar Ramappa; Emmanouil Telakis; Jayan Mannath; Aida U Jawhari; Christopher J Hawkey; Krish Ragunath
Journal:  Inflamm Bowel Dis       Date:  2013-02       Impact factor: 5.325

8.  Most dysplasia in ulcerative colitis is visible at colonoscopy.

Authors:  Matthew D Rutter; Brian P Saunders; Kay H Wilkinson; Michael A Kamm; Christopher B Williams; Alastair Forbes
Journal:  Gastrointest Endosc       Date:  2004-09       Impact factor: 9.427

9.  Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?

Authors:  David T Rubin; Jami A Rothe; Jeremy T Hetzel; Russell D Cohen; Stephen B Hanauer
Journal:  Gastrointest Endosc       Date:  2007-04-23       Impact factor: 9.427

10.  Chromoendoscopy versus narrow band imaging for colonic surveillance in inflammatory bowel disease.

Authors:  Marios Efthymiou; Patrick B Allen; Andrew C F Taylor; Paul V Desmond; Chatura Jayasakera; Peter De Cruz; Michael A Kamm
Journal:  Inflamm Bowel Dis       Date:  2013-09       Impact factor: 5.325
View more
  3 in total

1.  Diagnostic classification of endosonography for differentiating colorectal ulcerative diseases: A new statistical method.

Authors:  En-Qi Qiu; Wen Guo; Tian-Ming Cheng; Yong-Li Yao; Wei Zhu; Si-De Liu; Fa-Chao Zhi
Journal:  World J Gastroenterol       Date:  2017-12-14       Impact factor: 5.742

2.  Rapid on-site evaluation (ROSE) with EUS-FNA: The ROSE looks beautiful.

Authors:  Fei Yang; Enshuo Liu; Siyu Sun
Journal:  Endosc Ultrasound       Date:  2019 Sep-Oct       Impact factor: 5.628

3.  Clinical and prognostic significance of Raf kinase inhibitory protein expression in gastrointestinal stromal tumors.

Authors:  Yang Wang; Juan-Juan Chen; Xiao-Fei Wang; Qiang Wang
Journal:  World J Gastroenterol       Date:  2018-06-21       Impact factor: 5.742
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.